ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

28
Analysis
Health Care • United States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Company Event • 05 Nov 2026 05:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 13 Oct 2026 20:00 • Upcoming
Add To Calendar

Corporate presentation

Company Event • 24 Sep 2026 20:00 • Latest

Study result

Company Event • 13 Aug 2026 01:30

Canaccord Genuity's 46th Annual Growth Conference

Company Event • 05 Aug 2026 04:30

Q2 2026

x